Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Ahmet Taner Sümbül; Umut Dişel; Nurzen Sezgin; Ahmet Sezer; Fatih Köse; Ali Ayberk Beşen; Zehra Sümbül; Hüseyin Abalı; Özgür Özyılkan

doi:10.12659/MSM.889945

15 March 2014 : Original article

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Ahmet Taner Sümbül^ABCDEFG, Umut Dişel^ABCD, Nurzen Sezgin^AB, Ahmet Sezer^ABCD, Fatih Köse^ABCD, Ali Ayberk Beşen^ABCD, Zehra Sümbül^ABCD, Hüseyin Abalı^ABCD, Özgür Özyılkan^ABCD

DOI: 10.12659/MSM.889945

Med Sci Monit 2014; 20:428-433

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Your Privacy